Furthermore, in vivo data demonstrated that lncRNA HOXA-AS2 silencing suppressed Treg cell proliferation, which resulted in reduced secretion of TGF-β and IL-10 in spleen and finally reduced immune tolerance in glioma. Here, IL10 is linked to central nervous system cancer.